Clinigen Group PLC has completed the €7.5 million acquisition of Swiss pharmaceutical company iQone Healthcare Holding (Suisse) SA.

The deal represents €5 million in cash and €2.5 million in new Clinigen shares issued to iQone Healthcare, with the possibility of additional payments based on certain future EBITDA targets.

The acquisition complements U.K.-based Clinigen's unlicensed and commercial divisions and the acquired company will help expand Clinigen's business in Europe.

Clinigen is also in the process of acquiring CSM Parent Inc. in a $150 million deal to expand its supply and distribution network.